Fayez Sarofim & Co’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,290
Closed -$227K 313
2024
Q3
$227K Hold
3,290
﹤0.01% 272
2024
Q2
$210K Hold
3,290
﹤0.01% 270
2024
Q1
$309K Hold
3,290
﹤0.01% 251
2023
Q4
$232K Hold
3,290
﹤0.01% 271
2023
Q3
$205K Hold
3,290
﹤0.01% 278
2023
Q2
$243K Hold
3,290
﹤0.01% 261
2023
Q1
$259K Hold
3,290
﹤0.01% 255
2022
Q4
$225K Buy
+3,290
New +$209K ﹤0.01% 265
2022
Q3
Sell
-3,290
Closed -$206K 280
2022
Q2
$206K Hold
3,290
﹤0.01% 284
2022
Q1
$212K Hold
3,290
﹤0.01% 316
2021
Q4
$276K Hold
3,290
﹤0.01% 305
2021
Q3
$257K Hold
3,290
﹤0.01% 292
2021
Q2
$250K Hold
3,290
﹤0.01% 301
2021
Q1
$211K Buy
+3,290
New +$198K ﹤0.01% 282
2017
Q4
Sell
-7,060
Closed -$210K 249
2017
Q3
$210K Hold
7,060
﹤0.01% 233
2017
Q2
$204K Buy
+7,060
New +$182K ﹤0.01% 236
2016
Q2
Sell
-8,145
Closed -$228K 245
2016
Q1
$228K Sell
8,145
-1,600
-16% -$39.9K ﹤0.01% 231
2015
Q4
$237K Buy
+9,745
New +$202K ﹤0.01% 234
2014
Q4
Sell
-10,375
Closed -$192K 253
2014
Q3
$192K Sell
10,375
-2,600
-20% -$55.6K ﹤0.01% 262
2014
Q2
$315K Buy
+12,975
New +$282K ﹤0.01% 222

Other funds holding BRKR

Fayez Sarofim & Co's BRKR Position: Q4 2024 in Review

Fayez Sarofim & Co sold out of Bruker (BRKR) in Q4 2024, closing a stake of 3,290 shares — an estimated $227K sold.

Fayez Sarofim & Co first reported a position in BRKR in Q2 2014 and held it in 20 quarters. The position peaked at $315K in Q2 2014. 367 funds tracked by Wall St. Rank hold BRKR as of Q4 2024.

  • Fayez Sarofim & Co reported no remaining Bruker position as of Q4 2024 after selling out during the quarter.
  • Fayez Sarofim & Co sold 3,290 Bruker shares in Q4 2024, an estimated $227K.
  • Fayez Sarofim & Co first reported a position in Bruker in Q2 2014 and held it in 20 quarters.
  • Fayez Sarofim & Co's Bruker position peaked at $315K in Q2 2014.
  • 367 funds tracked by Wall St. Rank held Bruker as of Q4 2024.

Based on Fayez Sarofim & Co's 13F filing for Q4 2024, filed 14 Feb 2025.